FDA to review Samsung Bioepis' application for anti-arthritis biosimilar September 27, 2018/0 Comments/in Hidradenitis suppurativa /by Steve… pediatric plaque psoriasis, adult and adolescent hidradenitis suppurativa, Crohn's disease, pediatric Crohn's disease, ulcerative colitis, and uveitis. Source link Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Google+ (Opens in new window) Related https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png 0 0 Steve https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png Steve2018-09-27 09:31:432018-09-27 09:31:43FDA to review Samsung Bioepis' application for anti-arthritis biosimilar
Leave a Reply
Want to join the discussion?Feel free to contribute!